User menu

Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia.

Bibliographic reference Detrait, M. ; Pothen, D. ; Brenard, R. ; Starkel, Peter ; Hermans, Cédric. Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia.. In: Haemophilia : the official journal of the World Federation of Hemophilia, Vol. 13, no. 5, p. 588-92 (2007)
Permanent URL
  1. Aledort LM, Blood, 66, 367 (1985)
  2. Hay CR, Blood, 69, 1595 (1987)
  3. Makris M., Preston F. E., Rosendaal F. R., Underwood J. C. E., Rice K. M., Triger D. R., The natural history of chronic hepatitis C in haemophiliacs, 10.1046/j.1365-2141.1996.02343.x
  4. Lang Leslie, NIH consensus development conference updates HCV management, 10.1053/gast.2002.1230404
  5. Lee C. A., Kessler C. M., Varon D., Martinowitz U., Heim M., FUKUDA Y., NAKANO I., KATANO Y., TOYODA H., IMOTO M., TAKAMATSU J., SAITO H., HAYAKAWA T., Assessment and treatment of liver disease in Japanese haemophilia patients, 10.1046/j.1365-2516.1998.440595.x
  6. Hanley John, Jarvis Lisa, Andrews Janet, Dennis Rosemary, Lee Robert, Simmonds Peter, Piris Juan, Hayes Peter, Ludlam Christopher A., Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods, 10.1046/j.1365-2141.1996.6192064.x
  7. LESESNE HENRY R., Liver Biopsy in Hemophilia A, 10.7326/0003-4819-86-6-703
  8. McMahon C., Pilkington R., Shea E. O., Kelleher D., Smith O. P., Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders, 10.1046/j.1365-2141.2000.02004.x
  9. Preston F.E., Underwood J.C.E., Mitchell V.E., Triger D.R., Bardhan G., Stpwart R.M., Blackburn E.K., PERCUTANEOUS LIVER BIOPSY AND CHRONIC LIVER DISEASE IN HÆMOPHILIACS, 10.1016/s0140-6736(78)92821-0
  10. Ahmed M. M., Mutimer D. J., Elias E., Linin J., Garrido M., Hubscher S., Jarvis L., Simmonds P., Wilde J. T., A combined management protocol for patients with coagulation disorders infected with hepatitis C virus, 10.1046/j.1365-2141.1996.d01-1899.x
  11. Dawson M. A., McCarthy P. H., Walsh M. E., McLean C. A., Thomson K., Roberts S., Street A. M., Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C : Transjugular liver biopsy in CBD, 10.1111/j.1445-5994.2005.00877.x
  12. DiMichele D. M., Mirani G., Wilfredo Canchis P., Trost D. W., Talal A. H., Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection, 10.1046/j.1365-2516.2003.00801.x
  13. Farrell Richard J, Smiddy Pauline F, Pilkington Ruth M, Tobin Anne A, Mooney Eoghan E, Temperley Ian J, McDonald George S, Bowmer Heather A, Wilson Graham F, Kelleher Dermot, Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs, 10.1016/s0168-8278(99)80187-1
  14. Fried Michael W, Management of hepatitis C in the hemophilia patient, 10.1016/s0002-9343(99)00391-5
  15. Brenard R, Acta gastroenterological Belgica, 60, 138 (1997)
  16. Ludwig Jurgen, The nomenclature of chronic active hepatitis: An obituary, 10.1016/0016-5085(93)90037-d
  17. Bedossa P, Poynard T, An algorithm for the grading of activity in chronic hepatitis C, 10.1002/hep.510240201
  18. Shin Jennifer L., Teitel Jerome, Swain Mark G., Bain Vincent G., Adams Paul C., Croitoru Kenneth, Peltekian Kevork, Schweiger Frank, Simons Martin E., Heathcote E. Jenny, A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful?, 10.1002/ajh.20263
  19. Stieltjes Natalie, Ounnoughene Nadra, Sava Emilie, Paugy Patricia, Roussel-Robert Valerie, Rosenberg Arielle R., Terris Benoit, Salmon-Ceron Dominique, Sogni Philippe, Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus, 10.1111/j.1365-2141.2004.04968.x
  20. Venkataramani A., Behling C., Rond R., Glass C., Lyche K., Liver biopsies in adult hemophiliacs with hepatitis C: a United States center's experience, 10.1111/j.1572-0241.2000.02338.x
  21. White GC, Blood, 60, 1259 (1982)
  22. Wong K. F., Tse K. T., Lee A. W. C., Mak C. S. L., So C. C., Is antenatal antibody screening worthwhile in Chinese?, 10.1046/j.1365-2141.1997.1292944.x
  23. Lethagen Stefan, Widell Anders, Berntorp Erik, Verbaan Hans, Lindgren Stefan, Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease, 10.1046/j.1365-2141.2001.02700.x
  24. Makris M, Blood, 78, 1672 (1991)
  25. POSTHOUWER D., MAUSER-BUNSCHOTEN E. P., FISCHER K., MAKRIS M., Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature, 10.1111/j.1365-2516.2006.01317.x